Effect of Champakadi Agad in the Management of Shitapitta w.s.r. to Urticaria - A case study
Keywords:Shitapitta, Urticaria, Champakadi Agad, Keeta-Luta Visha, Ayurvedic Formulations
Introduction: Shitapitta is a skin ailment that was first reported in Madhava Nidan which can be correlated to urticaria. It is a disorder characterized by symptoms comparable to Insect and scorpion bite, such as wheals resembling those from a wasp sting, itching, pain, fever, and burning feeling. Champakadi Agad is one of the Ayurveda formulations listed in Chapter 37/71-72 of Ashtanga Hridaya Uttarasthana by Acharya Vagbhata. Agadas are used to cure a variety of toxic conditions. Aims: To study the effect of Champakadi agad for local as well as internal use in case of Shitapitta. Case Report: This article is a case study about a 24 yrs old female patient who came to the OPD of Panchakarma Dept of Dr. D. Y. Patil College and hospital, Pimpri, Pune complaining of itchy skin, raised reddish bumps over the skin along with burning and pricing pain over her both palms and cheeks. She was treated with Champakadi Agad’s Local application for 30 days. Results after 30 days was found satisfactory. With no negative side effects, the therapy methods significantly reduced the disease's indications and symptoms. Discussion:This is a case study based on the management of Shitapitta (Urticaria). This study established the role of Champakadi Agad in the treatment of Shitapitta (Urticaria). Conclusion:The treatment of Shitapitta by Ayurvedic measures has been thoroughly examined and discussed here. Her progression is also shown here, step by step. This case study will encourage further research and aid in the development of an ayurvedic treatment protocol for Shitapitta (Urticaria).
How to Cite
Copyright (c) 2024 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.